Home » Topics » BioWorld Science

BioWorld Science
RSS

RXi Pharmaceuticals enters research agreement with Iovance Biotherapeutics

May 14, 2018

First patient dosed in phase II study of eFT-508 plus avelumab in colorectal cancer

May 14, 2018

Mitsubishi Tanabe presents milestones of fourth quarter of fiscal 2017

May 14, 2018

New phase II proof-of-concept trial studies IXT-m200 in methamphetamine users

May 11, 2018

Lipimetix sublicenses Apo E mimetic peptide platform to Anji

May 11, 2018

Phase III GALATHEA trial of Fasenra in COPD does not meet primary endpoint

May 11, 2018

FDA advisory committee votes in favor of Waylivra for familial chylomicronemia syndrome

May 11, 2018

KemPharm reports topline data from human abuse potential trial with KP-415 prodrug

May 11, 2018

CARB-X supports Talis' development of diagnostics to detect chlamydia and gonorrhea

May 11, 2018

SymBio enters joint research agreement with Keio University to evaluate Treakisym for SLE

May 11, 2018

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...